Completed PHASE4 INTERVENTIONAL 1-arm NCT00766532

Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption?

Sponsor: University of Wisconsin, Madison

Conditions Breast Cancer Fracture Osteopenia Osteoporosis

Updated 5 times since 2017 Last updated: Sep 13, 2012 Started: Jan 31, 2009 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00766532, this PHASE4 trial focuses on Breast Cancer and Fracture and remains completed. Sponsored by University of Wisconsin, Madison, it has been updated 5 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Wisconsin, Madison

Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.